Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Autor: Margolis, David A, Gonzalez-Garcia, Juan, Stellbrink, Hans-Jürgen, Eron, Joseph J, Yazdanpanah, Yazdan, Podzamczer, Daniel, Lutz, Thomas, Angel, Jonathan B, Richmond, Gary J, Clotet, Bonaventura, Gutierrez, Felix, Sloan, Louis, Clair, Marty St, Murray, Miranda, Ford, Susan L, Mrus, Joseph, Patel, Parul, Crauwels, Herta, Griffith, Sandy K, Sutton, Kenneth C, Dorey, David, Smith, Kimberly Y, Williams, Peter E, Spreen, William R
Zdroj: In The Lancet 23-29 September 2017 390(10101):1499-1510
Databáze: ScienceDirect